Delving into the Latest Updates on Jiuwei Shufeng Pingchuan Granules with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Immune System DiseasesRespiratory Diseases

Active Indication

Asthma

Inactive Indication-

Originator Organization

Jiangsu Kanion Pharmaceutical Co., Ltd.

Active Organization

Jiangsu Kanion Pharmaceutical Co., Ltd.

Inactive Organization-

License Organization-

Drug Highest PhasePhase 2

First Approval Date-

Regulation-

Login to view timeline

1.初步评价九味疏风平喘颗粒治疗支气管哮喘慢性持续期（风哮证）的有效性 2.初步评价九味疏风平喘颗粒治疗支气管哮喘慢性持续期（风哮证）的安全性 3.探索九味疏风平喘颗粒治疗支气管哮喘慢性持续期（风哮证）最佳用药剂量，为III期临床试验提供依据

[Translation]

1. Preliminary evaluation of the effectiveness of Jiuwei Shufeng Pingchuan Granules in the treatment of chronic persistent bronchial asthma (wind asthma syndrome) 2. Preliminary evaluation of the safety of Jiuwei Shufeng Pingchuan Granules in the treatment of chronic persistent bronchial asthma (wind asthma syndrome) 3. Explore the optimal dosage of Jiuwei Shufeng Pingchuan Granules in the treatment of chronic persistent bronchial asthma (wind asthma syndrome) to provide a basis for Phase III clinical trials

Start Date09 Jun 2023

Sponsor / Collaborator

Jiangsu Kanion Pharmaceutical Co., Ltd.

100 Clinical Results associated with Jiuwei Shufeng Pingchuan Granules

Login to view more data

100 Translational Medicine associated with Jiuwei Shufeng Pingchuan Granules

Login to view more data

100 Patents (Medical) associated with Jiuwei Shufeng Pingchuan Granules

Login to view more data

100 Deals associated with Jiuwei Shufeng Pingchuan Granules

Login to view more data